Roohbakhsh Maher
Podiatrist · Redondo Beach, CANPI 1275581357
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,493 of the $2,063 with a category attached, or 72.4%. 22 manufacturers reported payments, led by Treace Medical Concepts, Inc. at 32.4% of the total. Reporting peaked in 2019 at $1,156 and has fallen 69.8% since, to $349 in 2025.
Across 36 payments — averaging $57.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$668
- Novo Nordisk$375
- In2bones USA, LLC$146
- Zimmer Biomet$126
- Paragon 28, Inc.$101
- Integra Lifesciences Corporation$74
- plus $574 from 16 others
What the payments were for
- Travel & lodging$57028%
- Food & beverage$1,49372%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 3 | $668 |
| Novo Nordisk | 3 | $375 |
| In2bones USA, LLC | 1 | $146 |
| Zimmer Biomet | 1 | $126 |
| Paragon 28, Inc. | 1 | $101 |
| Integra Lifesciences Corporation | 3 | $74 |
| Sandoz | 3 | $64 |
| Amniox Medical, Inc. | 4 | $60 |
| Stryker | 1 | $48 |
| Johnson & Johnson | 1 | $43 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $43 |
| Dynavax Technologies Corporation | 2 | $39 |
| Melinta Therapeutics, LLC | 1 | $35 |
| DJO, LLC | 1 | $34 |
| Amgen | 2 | $32 |
| Viiv Healthcare Company | 1 | $31 |
| Smith+Nephew | 1 | $29 |
| Bioventus LLC | 1 | $29 |
| GSK | 1 | $26 |
| Sanofi Pasteur Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $21 |
| Convatec Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$570
- Wegovy$250
- Reference Toe System$146
- CoLink$146
- Foot & Ankle Product Portfolio$126
- Ozempic$125
How this compares
$2,063 in reported general payments places this provider in the 65th percentile of 721 podiatrist providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 445 | $10,820 |
| Ammonium Lactate | 107 | $2,691 |
| Clotrimazole | 49 | $1,656 |
| CiclopiroxCiclopirox Olamine | 23 | $1,074 |
| Diclofenac Sodium | 11 | $121 |
| Allopurinol | 11 | $62 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Redondo Beach
- Shannon RushPleasanton$1.9M
- Babak BaravarianSanta Monica$1.1M
- Robert KleimanCalexico$913K
- Bruce LawrenceOceanside$810K
- David ArmstrongLos Angeles$695K
- Philip WrotslavskyPoway$269K
- Travis WestermeyerEncinitas$158K
- Adrienne EstesPomona$129K
- Ronald LiebermanEncinitas$109K
- Matthew DoyleMountain View$92K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.